GGrantIndex
Sort

17,828 grants matching crispr

Discovery and characterization of a novel acylcarnitine transporter in brown adipocytes

$272,125
Judith Anne Simcox · University Of Wisconsin-Madison · R01 · FY2022 · DK

Sequencing Technologies & Analysis Shared Resource

$272,102
William Richard McCombie · Cold Spring Harbor Laboratory · P30 · FY2024 · CA

Molecular mechanisms of the mitochondrial calcium uniporter

$271,767
Ming-Feng Tsai · University Of Colorado Denver · R01 · FY2018 · GM

Arsenic-Induced miRNA-199 and mriRNA-214 Deplete Mitochondrial DNA for the Generation of Cancer Stem-Like Cells

$271,530
Fei Chen · State University New York Stony Brook · R01 · FY2022 · ES

Arsenic-Induced miRNA-199 and mriRNA-214 Deplete Mitochondrial DNA for the Generation of Cancer Stem-Like Cells

$271,530
Fei Chen · State University New York Stony Brook · R01 · FY2021 · ES

Collaborative Research: Mechanisms of RNA-directed activation of a Cas9 nuclease competent for DNA interrogation.

$271,411
Peter Z Qin · University Of Southern California · · FY2017 · BIO

In Vivo Gene Editing of B cells with NICE-AAV Vectors

$271,147
Christopher W Peterson · Fred Hutchinson Cancer Research Center · R01 · FY2022 · AI

Core 2: In vivo cancer modeling and screening core facility

$271,099
Sidi Chen · Yale University · U54 · FY2016 · CA

The TMEM16 Family of Ion Channels and Lipid Scramblases

$271,087
Lily Y Jan · University Of California, San Francisco · R35 · FY2021 · NS

Exploiting Therapeutic Vulnerabilities

$270,796
William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA

Molecular and Cellular Biology Core

$270,638
Philip Ross Hardwidge · Kansas State University · P20 · FY2021 · GM

Molecular and Cellular Biology Core

$270,638
Philip Ross Hardwidge · Kansas State University · P20 · FY2022 · GM

Study of M. tuberculosis under human host selection to identify virulence and barrier lipids (Project 1)

$270,429
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2024 · AI

CRISPR-assisted provirus tagging in vitro

$270,197
Keith R Jerome · Fred Hutchinson Cancer Research Center · R21 · FY2019 · AI

PROJECT 1

$270,112
Reuben S Harris · University Of Minnesota · P01 · FY2019 · CA

Preclinical development of gene-edited human hematopoietic stem cells

$270,000
Rodger Novak · Harvard University · U19 · FY2018 · HL

Preclinical development of gene-edited human hematopoietic stem cells

$270,000
Rodger Novak · Harvard University · U19 · FY2016 · HL

Frugal Science Academy: Training K-12 innovators and democratizing synthetic biology tools

$270,000
Saad Bhamla · Georgia Institute Of Technology · R25 · FY2022 · GM

Preclinical development of gene-edited human hematopoietic stem cells

$270,000
Rodger Novak · Harvard University · U19 · FY2017 · HL

Matrix Organization and Dimensionality

$269,952
Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE

Development and Validation of a Novel Cas13a and Nanoparticle Guide-RNA Delivery System that Allows Precise Ablation of Host Macrophage Populations in a Humanized Mouse Model

$269,900
Michael Van Wiles · Jackson Laboratory · R21 · FY2019 · OD

Project 1: Targeting Metastatic Prostate Cancer Patients with Biallelic Loss of CDK12

$269,895
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2020 · CA

Novel transgenesis and expression technology for nematodes

$269,875
Michael L Nonet · Washington University · R01 · FY2021 · GM

Establishment and visualization of nuclear architecture at the onset of mammalian development

$269,822
Maria Elena Torres Padilla · Helmholtz Zentrum Muenchen - Gmbh · U01 · FY2020 · DK

STTR Phase I: Harnessing CRISPR-mediated silencing for the one-step optimization of protein production strains

$269,757
Ellen M Brune · Boston Mountain Biotech, Llc · · FY2016 · TIP